Your browser doesn't support javascript.
loading
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials.
Warren, Richard B; Gottlieb, Alice B; Merola, Joseph F; Garcia, Llenalia; Cioffi, Christopher; Peterson, Luke; Pelligra, Christopher; Ciaravino, Valerie.
Affiliation
  • Warren RB; Dermatology Centre, Manchester NIHR Biomedical Research Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Stott Lane, Salford, M6 8HD, Greater Manchester, UK. Richard.Warren@manchester.ac.uk.
  • Gottlieb AB; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Merola JF; Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • Garcia L; UCB Pharma, Slough, UK.
  • Cioffi C; UCB Pharma, Raleigh, NC, USA.
  • Peterson L; UCB Pharma, Raleigh, NC, USA.
  • Pelligra C; Evidera, Medellín, Colombia.
  • Ciaravino V; UCB Pharma, Colombes, France.
Dermatol Ther (Heidelb) ; 11(5): 1551-1569, 2021 10.
Article in En | MEDLINE | ID: mdl-34260044
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland